10.05.26 -- Why Are We Still Talking About Compensating Research Participants?

Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.

Maximize your trial agility by replacing slow, linear start-ups with parallel workflows and rapid SLAs. Partnering with agile sites secures a commercial edge and predictable timelines.

Some sites lack the advanced ophthalmic support to run vision-related trials, but we work alongside your team to deliver the data you need, where and when you need it.

This panel discussion shines a light on how patient advocacy groups are rewriting the playbook on patient recruitment, education, feasibility, and real-world study support across rare diseases.

A participant's preferred payment method can make or break retention. Learn how flexible, participant-friendly compensation benefits both study volunteers and trial success.

Master trial governance with 10 core principles. Learn how tracking trends, rewarding transparency, and early escalation ensure long-term trial success.

Recruiting for rare acute diseases is challenging. Discover how this organization used rapid site activation and investigator engagement to speed enrollment in a Phase III Anti-GBM trial.

This AI-powered platform is helping CROs and sponsors tackle the unsolved challenge they've faced for decades: clinical trials that launch late, recruit slowly, and miss enrollment targets.

Accelerate endocrinology and metabolic trials. Discover global regulatory strategies, decentralized models, and patient-centric recruitment data to optimize your clinical development.

Examples of how embedded community sites and local events show how authentic on‑the‑ground involvement translates into deeper patient relationships and measurable study outcomes.